217 related articles for article (PubMed ID: 21546017)
1. [Thyroid dysfunction in patients with chronic hepatitis C treated with pegylated interferon alpha].
Montero-Tinnirello J; de la Fuente-Aguado J; Rodríguez-Pecci MS; Fernández-Fernández FJ
Rev Clin Esp; 2011 Sep; 211(8):436-8. PubMed ID: 21546017
[No Abstract] [Full Text] [Related]
2. Thyrotoxic periodic paralysis induced by pegylated interferon alpha plus ribavirin for chronic hepatitis C.
Yang WS; Chu PL; Liu CH; Chung GB; Wu KD
J Clin Gastroenterol; 2008 Jan; 42(1):112-3. PubMed ID: 18097301
[No Abstract] [Full Text] [Related]
3. Thyroid function and changes in ultrasound morphology during antiviral therapy with pegylated interferon and ribavirin in patients with chronic hepatitis C.
Friedrich-Rust M; Theobald J; Zeuzem S; Bojunga J
J Viral Hepat; 2009 Mar; 16(3):168-77. PubMed ID: 19175874
[TBL] [Abstract][Full Text] [Related]
4. Pegylated interferon associated lichen planus at the injection site.
Ergül B; Koçak E; Akbal E; Köklü S; Astarci HM
Acta Gastroenterol Belg; 2011 Dec; 74(4):591-2. PubMed ID: 22319976
[No Abstract] [Full Text] [Related]
5. Erythema gyratum repens induced by pegylated interferon alfa for chronic hepatitis C.
Rongioletti F; Fausti V; Parodi A
Arch Dermatol; 2012 Oct; 148(10):1213-4. PubMed ID: 23069974
[No Abstract] [Full Text] [Related]
6. Reversible sudden sensorineural hearing loss during chronic hepatitis C treatment with pegylated interferon/ribavirin.
Papastergiou V; Skorda L; Lisgos P; Karatapanis S
Acta Gastroenterol Belg; 2011 Dec; 74(4):582-4. PubMed ID: 22319972
[No Abstract] [Full Text] [Related]
7. Commentary: efficacy and safety of ribavirin plus pegylated interferon-alpha in geriatric patients with chronic hepatitis C - authors' reply.
Hu CC; Chien RN
Aliment Pharmacol Ther; 2013 Feb; 37(4):492. PubMed ID: 23336679
[No Abstract] [Full Text] [Related]
8. [Analysis of thyroid dysfunction and influencing factors in chronic hepatitis C patients treated with peg-IFNa-2a and ribavirin].
Huang YX; Chen XY; Ma LN; Yin JM; Ren S; Guo DD; Zheng YH
Zhonghua Gan Zang Bing Za Zhi; 2012 Mar; 20(3):216-20. PubMed ID: 22475143
[TBL] [Abstract][Full Text] [Related]
9. Interferon-induced thyroid dysfunction--not always transient.
Wong VW; Cheng AY; Chan HL
J Gastroenterol Hepatol; 2009 Jun; 24(6):938-40. PubMed ID: 19638076
[No Abstract] [Full Text] [Related]
10. [Thyroid dysfunctions in children with chronic hepatitis C during interferon alpha-2b therapy].
Kupś-Rzepecka J; Woźniakowska-Gesicka T; Gołabek V
Przegl Lek; 2011; 68(6):311-5. PubMed ID: 22039668
[TBL] [Abstract][Full Text] [Related]
11. Penile paraffinoma developing during treatment with pegylated interferon alfa-2a for chronic hepatitis C virus infection.
Bachmeyer C; Moguelet P; Gombeaud T; Sbidian E; Aractingi S
Arch Dermatol; 2011 Oct; 147(10):1232-3. PubMed ID: 22006152
[No Abstract] [Full Text] [Related]
12. Choreiform movements associated with pegylated interferon-alpha in a patient with chronic hepatitis C.
Akin M; İşler M; Şenol A; Kutluhan S; Tüfekçı A
Turk J Gastroenterol; 2012; 23(5):618-9. PubMed ID: 23161317
[No Abstract] [Full Text] [Related]
13. [Has hepatitis C become curable by a new pegylated interferon?].
Trépo C; Merle P
Presse Med; 2001 May; 30(18):905-8. PubMed ID: 11413851
[No Abstract] [Full Text] [Related]
14. [Pegylated interferon and ribavirin associated retinopathy in patients with hepatitis C].
Burgueño-Montañés C; Pérez-Álvarez R
Arch Soc Esp Oftalmol; 2011 Jun; 86(6):193-5. PubMed ID: 21767697
[TBL] [Abstract][Full Text] [Related]
15. Black hairy tongue during interferon therapy for hepatitis C.
Arab JP; Vargas JI; Morales C; Arrese M
Ann Hepatol; 2015; 14(3):414-5. PubMed ID: 25864223
[No Abstract] [Full Text] [Related]
16. Cutaneous sarcoidosis associated with pegylated interferon alfa and ribavirin therapy in a patient with chronic hepatitis C.
Rogers CJ; Romagosa R; Vincek V
J Am Acad Dermatol; 2004 Apr; 50(4):649-50. PubMed ID: 15034524
[No Abstract] [Full Text] [Related]
17. Thyroid dysfunction in patients with chronic hepatitis C: virus- or therapy-related?
Vezali E; Elefsiniotis I; Mihas C; Konstantinou E; Saroglou G
J Gastroenterol Hepatol; 2009 Jun; 24(6):1024-9. PubMed ID: 19383078
[TBL] [Abstract][Full Text] [Related]
18. [Cutaneous necrosis due to injection of interferon-alpha 2b in a patient with chronic hepatitis C].
Castellanos González M; Pérez Carreras M; Muñoz Gómez R; Castellano Tortajada G
Gastroenterol Hepatol; 2011 Oct; 34(8):584-5. PubMed ID: 21641684
[No Abstract] [Full Text] [Related]
19. Autoimmune fulminant hepatic failure in chronic hepatitis C during Peg-interferon-alpha 2b plus ribavirin treatment showing histological heterogeneity.
Yasui S; Fujiwara K; Yokosuka O
Dig Liver Dis; 2011 Aug; 43(8):666-7. PubMed ID: 21435960
[No Abstract] [Full Text] [Related]
20. [Tuberculous lymphadenitis after successful treatment of hepatitis C].
Velasco J; González S
Enferm Infecc Microbiol Clin; 2011 Oct; 29(8):631. PubMed ID: 21570741
[No Abstract] [Full Text] [Related]
[Next] [New Search]
